BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19559722)

  • 1. Resveratrol induces senescence-like growth inhibition of U-2 OS cells associated with the instability of telomeric DNA and upregulation of BRCA1.
    Rusin M; Zajkowicz A; Butkiewicz D
    Mech Ageing Dev; 2009 Aug; 130(8):528-37. PubMed ID: 19559722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol Induced Premature Senescence Is Associated with DNA Damage Mediated SIRT1 and SIRT2 Down-Regulation.
    Kilic Eren M; Kilincli A; Eren Ö
    PLoS One; 2015; 10(4):e0124837. PubMed ID: 25924011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of p21WAF1/CIP1, pRB, Bax and NF-kappaB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A549 cells.
    Kim YA; Lee WH; Choi TH; Rhee SH; Park KY; Choi YH
    Int J Oncol; 2003 Oct; 23(4):1143-9. PubMed ID: 12963997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol inhibits proliferation and promotes apoptosis of osteosarcoma cells.
    Li Y; Bäckesjö CM; Haldosén LA; Lindgren U
    Eur J Pharmacol; 2009 May; 609(1-3):13-8. PubMed ID: 19285066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol with antioxidant activity inhibits matrix metalloproteinase via modulation of SIRT1 in human fibrosarcoma cells.
    Lee SJ; Kim MM
    Life Sci; 2011 Mar; 88(11-12):465-72. PubMed ID: 21238464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of prostate cell growth, DNA damage and repair and gene expression by resveratrol analogues, in vitro.
    Hsieh TC; Huang YC; Wu JM
    Carcinogenesis; 2011 Jan; 32(1):93-101. PubMed ID: 21045015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G2/M cell cycle arrest and induction of apoptosis by a stilbenoid, 3,4,5-trimethoxy-4'-bromo-cis-stilbene, in human lung cancer cells.
    Lee EJ; Min HY; Joo Park H; Chung HJ; Kim S; Nam Han Y; Lee SK
    Life Sci; 2004 Oct; 75(23):2829-39. PubMed ID: 15464834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults.
    Okawara M; Katsuki H; Kurimoto E; Shibata H; Kume T; Akaike A
    Biochem Pharmacol; 2007 Feb; 73(4):550-60. PubMed ID: 17147953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
    Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
    J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of resveratrol on the expression of a panel of genes interacting with the BRCA1 oncosuppressor in human breast cell lines.
    Le Corre L; Fustier P; Chalabi N; Bignon YJ; Bernard-Gallon D
    Clin Chim Acta; 2004 Jun; 344(1-2):115-21. PubMed ID: 15149879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel quinolone CHM-1 induces DNA damage and inhibits DNA repair gene expressions in a human osterogenic sarcoma cell line.
    Chen HY; Lu HF; Yang JS; Kuo SC; Lo C; Yang MD; Chiu TH; Chueh FS; Ho HC; Ko YC; Chung JG
    Anticancer Res; 2010 Oct; 30(10):4187-92. PubMed ID: 21036739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel quinazoline HMJ-30 induces U-2 OS human osteogenic sarcoma cell apoptosis through induction of oxidative stress and up-regulation of ATM/p53 signaling pathway.
    Chiu YJ; Hour MJ; Lu CC; Chung JG; Kuo SC; Huang WW; Chen HJ; Jin YA; Yang JS
    J Orthop Res; 2011 Sep; 29(9):1448-56. PubMed ID: 21425328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol delays replicative senescence of human mesothelial cells via mobilization of antioxidative and DNA repair mechanisms.
    Mikuła-Pietrasik J; Kuczmarska A; Rubiś B; Filas V; Murias M; Zieliński P; Piwocka K; Książek K
    Free Radic Biol Med; 2012 Jun 1-15; 52(11-12):2234-45. PubMed ID: 22579575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells.
    Delmas D; Passilly-Degrace P; Jannin B; Cherkaoui Malki M; Latruffe N
    Int J Mol Med; 2002 Aug; 10(2):193-9. PubMed ID: 12119558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol induces Sirt1-dependent apoptosis in 3T3-L1 preadipocytes by activating AMPK and suppressing AKT activity and survivin expression.
    Chen S; Xiao X; Feng X; Li W; Zhou N; Zheng L; Sun Y; Zhang Z; Zhu W
    J Nutr Biochem; 2012 Sep; 23(9):1100-12. PubMed ID: 22137261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth.
    Chen J; Zhang B; Wong N; Lo AW; To KF; Chan AW; Ng MH; Ho CY; Cheng SH; Lai PB; Yu J; Ng HK; Ling MT; Huang AL; Cai XF; Ko BC
    Cancer Res; 2011 Jun; 71(12):4138-49. PubMed ID: 21527554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol is an effective inducer of CArG-driven TNF-alpha gene therapy.
    Bickenbach KA; Veerapong J; Shao MY; Mauceri HJ; Posner MC; Kron SJ; Weichselbaum RR
    Cancer Gene Ther; 2008 Mar; 15(3):133-9. PubMed ID: 18157146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses.
    Whyte L; Huang YY; Torres K; Mehta RG
    Cancer Res; 2007 Dec; 67(24):12007-17. PubMed ID: 18089832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway.
    Yuan Q; Peng J; Liu SY; Wang CJ; Xiang DX; Xiong XM; Hu CP; Li YJ
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):630-5. PubMed ID: 20132235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.